🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Coagulation reference changes with Pregnancy ! Right reference range is the key to improve maternal/perinatal outcomes with life threatening coagulopathy - HELLP syndrome , TTP, HUS, DIC. Great reminder ! #ASH23 #ASH2023

We are spearheading pioneering research and clinical programs in SCD and gene therapy in California and with our global partners worldwide. As Director of the Sickle Cell Center of Excellence at Loma Linda University, we are advancing access to cutting-edge care and championing

#ISTH2025 wonderful collection of colleagues, educators and leaders in the field of blood disorders. Wonderful meeting so far. RPTH ATHN NBCA

A New Era in Haemophilia A Prophylaxis🌟 Dr. Shima presented groundbreaking phase I/II results for NXT007, a next-generation bispecific antibody: 30 patients with severe haemophilia A (no inhibitors), age range: 12-65 years (median age 39.5 years), subcutaneous dosing: 0.072-1.08

Total number of patients with hemophilia globally who have received Gene Therapy. Less than 100 pts overall received commercial GT since regulatory approval a few years ago. ● Good ? Bad ? ● Cost prohibitive in order for broader adoption ? ● Opportunity for Gene therapy2.0

Not a problem it was a very good symposium

🚀 Revolutionary megaTAL Technology. Jacob Lund and Novo Nordisk just dropped game-changing preclinical data at ISTH 2025! Their megaTAL nuclease platform precisely inserts FVIII genes into liver cells. Genomic insertion and FVIII expression were proportional to nuclease activity

#ISTH2025 thank you

As expected our tools in gene editing mastered in Hemoglobinopathies are finding a wider application in other #RareDisease. Next generation of blockbuster therapeutics!!! pubmed.ncbi.nlm.nih.gov/39967679/ ASGCT ASTCT Down's Syndrome JA

Hereditary hypofibrinogenemia: A rare cause of chronic liver disease - JPGN Reports - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/jp… ASH Clinical News ATHN ISTH WFH

intechopen.com/profiles/344600 Author profile #academia #MedTwitter

#Ramayana #Bollywood #SanatanDharma #universalpeace Hans Zimmer A.R.Rahman Music

bleeding.org/events/a-new-r… NBDF Nevada ATHN ISTH Fundación Nacional de Trastornos Hemorrágicos National Bleeding Disorders Foundation ASH Hope for Hemophilia MyHemophiliaTeam Bleeding Disorders Foundation of Florida

#ghibli #ArtificialIntelligence Grok Akshat Jain MD MPH FRCP

vumedi.com/video/hematolo… #blood #MedTwitter #podcast #Meeting #GlobalGoals ISTH ATHN ASH European Hematology Association Hope for Hemophilia GreatLakesHemophilia Bleeding Disorders Foundation of Florida Hemophilia Ontario HemophiliaMB National Organization for Rare Disorders (NORD) TED Talks World Health Organization (WHO) BloodStream Media Scripps Research Deloitte Life Sciences & Health Care

Great science being discussed at National Alliance of Sickle Cell Centers annual meeting! The Sickle cell Trait Natural history study #AUNT study promises some great insights !! Congratulations to all fellow investigator"s and sites that are moving forward to answer important questions for #sicklecell

Bone marrow isn’t just a blood cell factory—it’s a dynamic hub where rare cells and their “neighborhoods” shape healthy blood and fight disease. New discoveries unlock pathways for treating leukemia and reveal why #MarrowMatters for our future health. ashpublications.org/ashnewsdaily/b…

Will make for a terrific discussion! ISTH BloodStream Media ASH ATHN Hope for Hemophilia Hemophilia Federation of America (HFA)

Medical education! Young minds initiated into Hematology! Exciting academic year of teaching coming up! #MedEd #MedTwitter #education #healthcareai #Doctors #hematology The Doctors AMA Medicine.com ASH